Patents by Inventor Chiung-Wen WANG

Chiung-Wen WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NADPH oxidase inhibitors, pharmaceutical composition comprising the same, and application thereof
    Patent number: 11661400
    Abstract: The present disclosure relates to a compound of Formula I, or a geometric isomer, enantiomer, diastereomer, racemate, atropisomer, pharmaceutically acceptable salt, prodrug or solvate thereof. The present disclosure further relates to a composition comprising the compound of Formula (I). The compound and the composition described herein can be used to inhibit NADPH oxidase activity.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: May 30, 2023
    Assignee: TAIWANJ PHARMACEUTICALS CO., LTD.
    Inventors: Syaulan S. Yang, Kuang Yuan Lee, Meng Hsien Liu, Yan-Feng Jiang, Yu-Shiou Fan, Chiung Wen Wang, Mei-Chi Hsu
  • PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
    Publication number: 20220153687
    Abstract: The compounds represented by Formula (I), which are peripheral alkyl and alkenyl chains extended benzene derivatives, are useful as dual autotaxin (ATX)/histone deacetylase (HD AC) inhibitors. These compounds may be included in a pharmaceutical composition along with a pharmaceutically acceptable carrier, and be used in a therapeutically effective amount for prophylaxis or treatment of various diseases and disorders.
    Type: Application
    Filed: March 27, 2020
    Publication date: May 19, 2022
    Applicant: TAIWANJ PHARMACEUTICALS CO., LTD.
    Inventors: Syaulan S. YANG, Yan-feng JIANG, Meng-hsien LIU, Chia-hao CHANG, Hao Shiuan LIU, Ying-chu SHIH, Sheng Hung LIU, Chiung Wen WANG, Ting-ni HUANG
  • NADPH OXIDASE INHIBITORS, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND APPLICATION THEREOF
    Publication number: 20210276957
    Abstract: The present disclosure relates to a compound of Formula I, or a geometric isomer, enantiomer, diastereomer, racemate, atropisomer, pharmaceutically acceptable salt, prodrug or solvate thereof. The present disclosure further relates to a composition comprising the compound of Formula (I). The compound and the composition described herein can be used to inhibit NADPH oxidase activity.
    Type: Application
    Filed: June 20, 2019
    Publication date: September 9, 2021
    Applicant: TAIWANJ PHARMACEUTICALS CO., LTD.
    Inventors: Syaulan S. YANG, Kuang Yuan LEE, Meng Hsien LIU, Yan-Feng JIANG, Yu-Shiou FAN, Chiung Wen WANG, Mei-Chi HSU
  • SULFONAMIDE OR AMIDE COMPOUNDS, COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND/OR TREATMENT OF AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS
    Publication number: 20200247761
    Abstract: The present invention related to novel sulfonamides or amides as TLR-4 antagonists, and pharmaceutical formulations containing the same and the methods of use thereof. Uses of the present novel sulfonamides or amides include, but are not limited to, the prophylaxis and/or treatment of autoimmune, inflammation, or infection related disorders.
    Type: Application
    Filed: January 25, 2018
    Publication date: August 6, 2020
    Applicant: TAIWANJ PHARMACEUTICALS CO., LTD
    Inventors: Syaulan S. YANG, Kuang-Yuan LEE, Meng-Hsien LIU, Ming-Yu HSIAO, Huang-Kai PENG, Chiung-Wen WANG, Edwin SC WU, Peter JS CHIU